Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by starrunneron Apr 14, 2017 9:04am
184 Views
Post# 26122113

RE:RE:Competition....nothing close to Theralase (as of today!)

RE:RE:Competition....nothing close to Theralase (as of today!)
bionicjoe wrote: Competition is real. So real that on two separate Korelin shows RW alluded to the potential cause of the patient enrollment delays could stem from urologists recommending other clinical trials to their cancer patients. My guess is he wouldn't have said it if he didn't have first hand knowledge that it had affected his own trial. That's the CEO himself saying some patients on the advice of their specialists might be finding they have a better chance somewhere else. It would appear not every urologist and their desperate patients have seen the " light " yet like some SH posters.

There are many presentations of bladder cancer. Each patient will have a unique location of the cancer, specific symptoms and additional comorbidities that allow the Urologist to recommend the best treatment option for their specific condition.
There are also a plethora of clinical trials that may be available for their patients, not neccesarly related to just their bladder cancer. Many hospital ethics committees recomend only approaching patients for one study at a time to avoid conflict and overwhelming the patient with decisions.I feel it is a good thing that the PMH/UHN team is taking the time to perform clean studies like this, because PDT therapy really needs the scientific support to reach it's potential.
I read your posts from time to time because I appreciate an alternative view, but it really appears that you only have one motive for posting and it is  consistent with the description of a basher. I mean, why would anyone wth such disdain for a company continue to post negativity. Most sane people that have been unsuccseful with something would just walk away. It must really burn your a$$ to see that goals are finally being attained.
Happy Easter you poor wicked soul.

Bullboard Posts